NCT03383094
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03383094
Title Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Loren Mell, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85719 United States Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
H. Lee Moffitt Cancer Center & Research Facility Tampa Florida 33612 United States Details
Washington University School of Medicine, Siteman Cancer Center St Louis Missouri 63110 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field